Literature DB >> 22877752

Identification of hepatocyte growth factor activator (Hgfac) gene as a target of HNF1α in mouse β-cells.

Tsuyoshi Ohki1, Yoshifumi Sato, Tatsuya Yoshizawa, Ken-ichi Yamamura, Kentaro Yamada, Kazuya Yamagata.   

Abstract

HNF1α is a transcription factor that is expressed in pancreatic β-cells and mutations of the HNF1α gene cause a form of monogenic diabetes. To understand the role of HNF1α in pancreatic β-cells, we established the MIN6 β-cell line that stably expressed HNF1α-specific shRNA. Expression of the gene encoding hepatocyte growth factor (HGF) activator (Hgfac), a serine protease that efficiently activates HGF, was decreased in HNF1α KD-MIN6 cells. Down-regulation of Hgfac expression was also found in the islets of HNF1α (+/-) mice. Reporter gene analysis and the chromatin immunoprecipitation assay indicated that HNF1α directly regulates the expression of Hgfac in β-cells. It has been reported that HGF has an important influence on β-cell mass and β-cell function. Thus, HNF1α might regulate β-cell mass or function at least partly by modulating Hgfac expression.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22877752     DOI: 10.1016/j.bbrc.2012.07.134

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  6 in total

1.  DNA Methylation Markers of Type 2 Diabetes Mellitus Among Male Veterans With or Without Human Immunodeficiency Virus Infection.

Authors:  Raina Mathur; Qin Hui; Yunfeng Huang; Marta Gwinn; Kaku So-Armah; Matthew S Freiberg; Amy C Justice; Ke Xu; Vincent C Marconi; Yan V Sun
Journal:  J Infect Dis       Date:  2019-05-24       Impact factor: 5.226

2.  Low serum level of high-sensitivity C-reactive protein in a Japanese patient with maturity-onset diabetes of the young type 3 (MODY3).

Authors:  Tsuyoshi Ohki; Yoshihiko Utsu; Shinya Morita; Md Fazlul Karim; Yoshifumi Sato; Tatsuya Yoshizawa; Ken-Ichi Yamamura; Kentaro Yamada; Soji Kasayama; Kazuya Yamagata
Journal:  J Diabetes Investig       Date:  2014-04-10       Impact factor: 4.232

3.  Hyperoxia reduces insulin release and induces mitochondrial dysfunction with possible implications for hyperoxic treatment of neonates.

Authors:  Ingrid Hals; Tsuyoshi Ohki; Rinku Singh; Zuheng Ma; Anneli Björklund; Chandima Balasuriya; Hanne Scholz; Valdemar Grill
Journal:  Physiol Rep       Date:  2017-10-16

4.  HNF1α controls glucagon secretion in pancreatic α-cells through modulation of SGLT1.

Authors:  Yoshifumi Sato; Md Mostafizur Rahman; Masaki Haneda; Tomonori Tsuyama; Tomoya Mizumoto; Tatsuya Yoshizawa; Tadahiro Kitamura; Frank J Gonzalez; Ken-Ichi Yamamura; Kazuya Yamagata
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2020-07-22       Impact factor: 5.187

5.  Identification of differentially methylated region (DMR) networks associated with progression of nonalcoholic fatty liver disease.

Authors:  Kikuko Hotta; Aya Kitamoto; Takuya Kitamoto; Yuji Ogawa; Yasushi Honda; Takaomi Kessoku; Masato Yoneda; Kento Imajo; Wataru Tomeno; Satoru Saito; Atsushi Nakajima
Journal:  Sci Rep       Date:  2018-09-11       Impact factor: 4.379

Review 6.  HNF1A Mutations and Beta Cell Dysfunction in Diabetes.

Authors:  Yasutaka Miyachi; Takashi Miyazawa; Yoshihiro Ogawa
Journal:  Int J Mol Sci       Date:  2022-03-16       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.